Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Gross Profit (2017 - 2026)

Updated

Takeda Pharmaceutical (TAK) posted Gross Profit of $5.1 billion for the quarter ended Jun 30, 2026, down 5.6% from $5.4 billion a year earlier and down 1.6% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Gross Profit (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Takeda Pharmaceutical was $30.58 billion, down 0.8% year-over-year; for the year ended Mar 31, 2026, it was $5.4 billion, up 0.2% from the prior year.

  • Annual Gross Profit shows a five-year compound annual growth rate of -23.6% (years ended Mar 2021 to Mar 2026).
  • In prior years, Takeda Pharmaceutical's Gross Profit was $5.39 billion in the year ended Mar 31, 2025 (-5.3%), $5.69 billion in the year ended Mar 31, 2024 (+4.3%), $5.46 billion in the year ended Mar 31, 2023 (-75.1%) and $21.93 billion in the year ended Mar 31, 2022 (+5.5%).
  • Quarterly Gross Profit has run from a low of $4.42 billion in the quarter ended Dec 31, 2024 to a high of $15.81 billion in the quarter ended Sep 30, 2025 over five years.
  • On a year-over-year basis, Gross Profit increased in four of the last eight quarters, with an average year-over-year change of 0.0%.
  • The strongest year-over-year quarter for Gross Profit in the past five years was the quarter ended Mar 31, 2022, with growth of 19.8%; the weakest was the quarter ended Jun 30, 2026, with a decline of 5.6%.
  • According to Business Quant data, Gross Profit for the three prior quarters was $5.19 billion (quarter ended Mar 31, 2026), $4.48 billion (quarter ended Dec 31, 2025) and $15.81 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.10 Bn
Mar 31, 2026 5.19 Bn
Dec 31, 2025 4.48 Bn
Sep 30, 2025 15.81 Bn
Jun 30, 2025 5.40 Bn
Mar 31, 2025 5.38 Bn
Dec 31, 2024 4.42 Bn
Sep 30, 2024 15.62 Bn
Jun 30, 2024 5.02 Bn
Mar 31, 2024 5.54 Bn
Dec 31, 2023 4.52 Bn
Sep 30, 2023 15.02 Bn
Jun 30, 2023 5.10 Bn
Mar 31, 2023 5.58 Bn
Dec 31, 2022 4.58 Bn
Sep 30, 2022 15.47 Bn
Jun 30, 2022 5.39 Bn
Mar 31, 2022 5.85 Bn
Jun 30, 2021 6.47 Bn
Mar 31, 2021 4.88 Bn
API Access

Takeda Pharmaceutical Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=TAK&period=max&api_key=YOUR_API_KEY